MarketScreener Homepage > Equities > Swiss Exchange > Roche Holding AG ROG CH0012032048

Report

Delayed Swiss Exchange - 01/27 11:31:46 am
320.2	CHF		-0.85%

07:52a

REGENERON PHARMACEUTICALS : Reports Positive Interim Data with REGEN-COV Antibody Cocktail used as Passive Vaccine to Prevent COVID-19

07:50a

REGENERON : REGEN-COV Is Active Against U.K., South Africa SARS-CoV-2 Variants

07:34a

ROCHE : REGEN-COV(TM) antibody cocktail is active against SARS-CoV-2 variants first identified in the UK and South Africa

News

All News

Official Publications

Sector news

MarketScreener Strategies

All news about ROCHE HOLDING AG

07:52a	REGENERON PHARMACEUTICALS : Reports Positive Interim Data with REGEN-COV Antibod..	AQ
07:50a	REGENERON : REGEN-COV Is Active Against U.K., South Africa SARS-CoV-2 Variants	DJ
07:34a	ROCHE : REGEN-COV(TM) antibody cocktail is active against SARS-CoV-2 variants fi..	PU
04:50a	ROCHE : Invitation to Roche's virtual event on key ophthalmology data presented ..	PU
01/26	ROCHE HOLDINGS AG : Goldman Sachs maintains a Buy rating	MD
01/26	ROCHE : Partner Regeneron Says Antibody Cocktail Effective As Passive Vaccine Ag..	MT
01/26	ROCHE : Regeneron reports positive interim data with REGEN-COV(TM) antibody cock..	PU
01/26	CHUGAI PHARMACEUTICAL : Obtains Approval for Expanded Use of FoundationOne CDx C..	AQ
01/26	CHUGAI PHARMACEUTICAL : Dissolution of Forerunner Pharma Research	AQ
01/26	ROCHE : Turkish Competition Board Imposes Fines Against Roche And Novartis	AQ
01/25	ROCHE HOLDINGS AG : Oddo reaffirms its Sell rating	MD
01/25	CHUGAI PHARMACEUTICAL : and Taisho Terminate the Co-Marketing Agreement of Ediro..	AQ
01/25	ROCHE HOLDINGS AG : JP Morgan remains Neutral	MD
01/25	ROCHE : Eye Drug Faricimab Meets Primary Endpoint	DJ
01/25	ROCHE : Japan's Sysmex to Collaborate on Global Distribution of Hematology Produ..	MT
01/25	ROCHE : Meets Primary Endpoint in Studies for Faricimab in Age-Related Vision Lo..	MT
01/25	ROCHE : renews partnership with Sysmex to deliver haematology testing solutions	AQ
01/25	PRESS RELEASE : Roche renews partnership with Sysmex to deliver haematology test..	DJ
01/25	GENENTECH : 's Faricimab Meets Primary Endpoint in Two Global Phase III Studies ..	BU
01/25	PRESS RELEASE : Roche's faricimab meets primary -2-	DJ
01/25	ROCHE : faricimab meets primary endpoint in two global phase III studies and sho..	AQ
01/25	PRESS RELEASE : Roche's faricimab meets primary endpoint in two global phase III..	DJ
01/22	ROCHE HOLDINGS AG : Barclays reiterates its Buy rating	MD
01/21	ROCHE : Genentech's Esbriet Gets FDA Priority Review in Unclassifiable Interstit..	DJ
01/21	ROCHE : US FDA Accepts Roche's Lung Disease Therapy Esbriet For New Drug Review	MT
01/21	ROCHE : FDA grants priority review to Roche's Esbriet (pirfenidone) for unclassi..	PU
01/21	ROCHE : FDA Grants Priority Review to Genentech's Esbriet (pirfenidone) for Uncl..	BU
01/20	ROCHE : Arthritis Drug to Be Tested Further in Severe COVID-19 Cases After Confl..	MT
01/20	ROCHE : Conflicting COVID-19 results for Roche arthritis drug show more trials n..	RE
01/20	ROCHE : DZ Bank Lifts Price Target on Roche, Maintains Hold Recommendation	MT
01/20	ROCHE HOLDINGS AG : Credit Suisse sticks Neutral	MD
01/20	ROCHE : Liberum Lifts Price Target on Roche, Maintains Hold Recommendation	MT
01/20	ROCHE HOLDINGS AG : Jefferies maintains a Buy rating	MD
01/19	CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise..	AQ
01/18	ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the ind..	AQ
01/18	PRESS RELEASE : Roche Annual General Meeting 2021: Exercising of shareholder rig..	DJ
01/15	ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating	MD
01/14	Qiagen warns against using standard tests to track coronavirus variants	RE
01/13	CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..	AQ
01/13	ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..	MT
01/13	ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating	MD
01/12	ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail ..	MT
01/12	ROCHE : confirms US government agreement to purchase additional doses of Regener..	AQ
01/12	PRESS RELEASE : Roche confirms US government -2-	DJ
01/12	PRESS RELEASE : Roche confirms US government agreement to purchase additional do..	DJ
01/12	ROCHE : CHEPLAPHARM acquires the rights to Rivotril	AQ
01/12	ROCHE HOLDINGS AG : Receives a Buy rating from UBS	MD
01/12	ROCHE : Tecentriq-Avastin Treatment Improves Survival Rate in Liver Cancer Patie..	MT
01/12	ROCHE : to present updated data confirming Tecentriq in combination with Avastin..	AQ
01/12	PRESS RELEASE : Roche to present updated data -2-	DJ
01/12	PRESS RELEASE : Roche to present updated data confirming Tecentriq in combinatio..	DJ
01/11	REGENERON PHARMACEUTICALS : says antibodies likely potent vs virus variants, Lil..	RE
01/11	GLOBAL MARKETS LIVE: Tech giants and freedom of expression
01/11	ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients	RE
01/11	Regeneron says COVID-19 antibody therapy will likely help against variants	RE
01/11	ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients	RE
01/11	ROCHE : Xofluza approved by the European Commission for the treatment of influen..	AQ
01/11	Soaring virus cases knock European stocks off 10-month high	RE
01/11	ROCHE : Correction to Roche Influenza Treatment Article	DJ
01/11	ROCHE : Influenza Treatment Approved by European Commission	DJ
01/11	ROCHE : Debuts Two Automated Digital Pathology Image Analysis Algorithms for Bre..	MT
01/11	ROCHE : Gets EU Approval for Influenza Treatment Xofluza	MT
01/11	ROCHE : gets EU green light for influenza treatment Xofluza	RE
01/11	ROCHE : launches two digital pathology image analysis algorithms for precision p..	AQ
01/11	PRESS RELEASE : Roche launches two digital pathology image analysis algorithms f..	DJ
01/11	ROCHE : Xofluza approved by the European Commission for the treatment of influen..	AQ
01/11	PRESS RELEASE : Roche's Xofluza approved by the -2-	DJ
01/11	PRESS RELEASE : Roche's Xofluza approved by the European Commission for the trea..	DJ
01/08	COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; ar..	RE
01/08	Coronavirus variants may lead to false negative results with molecular tests ..	RE
01/08	ROCHE HOLDINGS AG : Morgan Stanley is less optimistic	MD
01/08	ROCHE : Morgan Stanley Maintains Price Target on Roche, Downgrades Recommendatio..	MT
01/08	ROCHE HOLDINGS AG : Berenberg gives a Neutral rating	MD
01/07	ROCHE : Sanofi Arthritis Drugs Lower Fatality Rates in Severe COVID-19 Patients	MT
01/07	Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patie..	RE

1 2 3 4 5 6 7 8 9 10 Next

Analysis

AstraZeneca shares fall on 'hefty' $39-billion Alexion deal